Acylcarnitines measurement
|
phenotype |
|
Laboratory Procedure
|
6
|
12
|
0.100 |
None |
1.000 |
1 |
1
|
2015 |
2015 |
Post cardiac arrest syndrome
|
disease |
|
Disease or Syndrome
|
9
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Diabetic encephalopathy
|
disease |
|
Disease or Syndrome
|
21
|
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
Sepsis-Associated Encephalopathy
|
disease |
Nervous System Diseases
|
Disease or Syndrome
|
57
|
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Muscle degeneration
|
disease |
Musculoskeletal Diseases
|
Disease or Syndrome
|
70
|
3
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Memory dysfunction
|
disease |
Mental Disorders
|
Mental or Behavioral Dysfunction
|
70
|
3
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cockayne Syndrome, Type I
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
80
|
42
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Glucose measurement
|
phenotype |
|
Laboratory Procedure
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
elevated blood glucose level
|
phenotype |
|
Finding
|
89
|
111
|
0.100 |
None |
1.000 |
1 |
1
|
2011 |
2011 |
Mitochondrial Myopathies
|
group |
Nutritional and Metabolic Diseases; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
121
|
19
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Sleep Apnea, Central
|
disease |
Respiratory Tract Diseases; Nervous System Diseases
|
Disease or Syndrome
|
122
|
17
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |
Renal interstitial fibrosis
|
disease |
Female Urogenital Diseases and Pregnancy Complications; Skin and Connective Tissue Diseases; Male Urogenital Diseases
|
Disease or Syndrome
|
138
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Muscular Dystrophy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
280
|
67
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Adrenoleukodystrophy
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Nutritional and Metabolic Diseases; Nervous System Diseases; Endocrine System Diseases
|
Disease or Syndrome
|
294
|
116
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Vascular inflammations
|
phenotype |
Cardiovascular Diseases
|
Disease or Syndrome
|
305
|
3
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Tubulointerstitial fibrosis
|
phenotype |
|
Disease or Syndrome
|
328
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Ureteral obstruction
|
phenotype |
Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
359
|
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Muscular Dystrophy, Duchenne
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
375
|
170
|
0.010 |
None |
1.000 |
1 |
|
2013 |
2013 |
Glaucoma, Primary Open Angle
|
disease |
Eye Diseases
|
Disease or Syndrome
|
383
|
222
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Meningioma, benign, no ICD-O subtype
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
404
|
30
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Adult Meningioma
|
disease |
Neoplasms; Nervous System Diseases
|
Neoplastic Process
|
405
|
30
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |
Serum albumin measurement
|
phenotype |
|
Laboratory Procedure
|
433
|
3282
|
0.100 |
None |
1.000 |
1 |
1
|
2010 |
2010 |
Acute pancreatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
435
|
51
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Pancreatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
502
|
80
|
0.020 |
None |
1.000 |
2 |
|
2018 |
2019 |
Renal fibrosis
|
disease |
Pathological Conditions, Signs and Symptoms; Female Urogenital Diseases and Pregnancy Complications; Male Urogenital Diseases
|
Disease or Syndrome
|
570
|
1
|
0.010 |
None |
1.000 |
1 |
|
2018 |
2018 |